Intervention Review

You have free access to this content

Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period

  1. Yukari Yaju1,
  2. Yaeko Kataoka2,
  3. Hiromi Eto3,
  4. Shigeko Horiuchi2,
  5. Rintaro Mori4,*

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 26 NOV 2013

Assessed as up-to-date: 9 MAY 2013

DOI: 10.1002/14651858.CD009328.pub2


How to Cite

Yaju Y, Kataoka Y, Eto H, Horiuchi S, Mori R. Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD009328. DOI: 10.1002/14651858.CD009328.pub2.

Author Information

  1. 1

    St. Luke's College of Nursing, Research Center for Development of Nursing Practice, Tsukiji, Chuo-ku, Tokyo, Japan

  2. 2

    St. Luke's College of Nursing, Maternal Infant Nursing and Midwifery, Akashi-cho, Chuo-ku, Tokyo, Japan

  3. 3

    Nagasaki University, Graduate School of Biomedical Sciences, Division of Reproductive Health-International Health Nursing, Nagasaki, Tokyo, Japan

  4. 4

    National Center for Child Health and Development, Department of Health Policy, Tokyo, Tokyo, Japan

*Rintaro Mori, Department of Health Policy, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, Tokyo, 166-0014, Japan. rintaromori@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 26 NOV 2013

SEARCH

[Figure 1]
Figure 1. 'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
[Figure 2]
Figure 2. 'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Oral methylergometrine versus placebo, Outcome 1 PPH (blood loss of 500 mL or more over the period of observation).
[Analysis 1.2]
Analysis 1.2. Comparison 1 Oral methylergometrine versus placebo, Outcome 2 Amount of lochia during the first 72-hour of the puerperium (g) (outcome not prespecified).
[Analysis 1.3]
Analysis 1.3. Comparison 1 Oral methylergometrine versus placebo, Outcome 3 Amount of lochia by 4 weeks postpartum (g) (outcome not prespecified).
[Analysis 1.4]
Analysis 1.4. Comparison 1 Oral methylergometrine versus placebo, Outcome 4 Duration of lochia of more than 4 weeks (outcome not prespecified).
[Analysis 1.5]
Analysis 1.5. Comparison 1 Oral methylergometrine versus placebo, Outcome 5 Endometritis (outcome not prespecified).
[Analysis 1.6]
Analysis 1.6. Comparison 1 Oral methylergometrine versus placebo, Outcome 6 Pain requiring analgesia (requests for paracetamol) (outcome not prespecified).
[Analysis 2.1]
Analysis 2.1. Comparison 2 Oral methylergometrine versus oral Kyuki-chouketsu-in, Outcome 1 Blood haemoglobin concentration at day 1 postpartum (g/dL).